ADMA Biologics, Inc. (ADMA)
NASDAQ: ADMA · Real-Time Price · USD
9.55
-0.03 (-0.31%)
Sep 4, 2026, 2:39 PM EDT - Market open

ADMA Biologics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
136.0287.63103.1551.3586.5251.09
Cash & Short-Term Investments
136.0287.63103.1551.3586.5251.09
Cash Growth
50.66%-15.04%100.86%-40.65%69.36%-8.64%
Receivables
138.23158.435027.4215.5128.58
Inventory
239.31206.47170.24172.91163.28124.72
Prepaid Expenses
14.647.468.035.335.14.34
Other Current Assets
-6.53----
Total Current Assets
528.2466.51331.41257.01270.4208.73
Property, Plant & Equipment
72.8171.7163.3463.4768.7558.2
Goodwill
3.533.533.533.533.533.53
Other Intangible Assets
0.580.630.460.51.011.73
Long-Term Deferred Tax Assets
69.9773.2684.28---
Other Long-Term Assets
9.138.65.664.674.774.07
Total Assets
684.21624.24488.68329.18348.46276.25

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
31.7222.5220.2215.6613.2312.43
Accrued Expenses
28.1127.6828.6330.5523.1916.23
Current Portion of Long-Term Debt
3.752.81----
Current Portion of Leases
1.181.11.221.050.910.59
Current Income Taxes Payable
6.228.623.48---
Current Unearned Revenue
---0.180.140.14
Other Current Liabilities
4.786.8222.371.80.98
Total Current Liabilities
75.7669.5455.5449.8139.2730.38
Long-Term Debt
192.8469.3372.34130.59142.8394.87
Long-Term Leases
6.076.658.569.7810.77.46
Long-Term Unearned Revenue
1.331.411.551.691.831.98
Other Long-Term Liabilities
--1.672.111.850.4
Total Liabilities
276146.92139.66193.98196.49135.08

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
0.020.020.020.020.020.02
Additional Paid-In Capital
675.14671.04657.58641.44629.97553.27
Retained Earnings
-78.5-161.65-308.58-506.26-478.02-412.11
Treasury Stock
-188.45-32.09----
Shareholders' Equity
408.21477.32349.02135.21151.97141.17
Total Liabilities & Equity
684.21624.24488.68329.18348.46276.25

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
203.8479.8982.12141.42154.44102.92
Net Cash (Debt)
-67.827.7521.03-90.07-67.92-51.83
Net Cash Growth
--63.17%----
Net Cash Per Share
-0.280.030.09-0.40-0.34-0.37
Filing Date Shares Outstanding
223.98238.16237.62228.22222.16195.92
Total Common Shares Outstanding
225.36237.87236.62226.06221.82195.81
Working Capital
452.45396.97275.87207.21231.14178.35
Book Value Per Share
1.812.011.480.600.690.72
Tangible Book Value
404.1473.16345.03131.18147.43135.91
Tangible Book Value Per Share
1.791.991.460.580.660.69
Land
13.0413.044.344.344.344.34
Buildings
27.626.8921.7920.2219.5419.07
Machinery
41.8840.0432.9232.9329.224.17
Construction In Progress
10.828.468.152.276.735.5
Leasehold Improvements
15.0514.9821.0720.8117.9311.13
SEC Filings: 10-K · 10-Q